Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

BACKGROUND Age-related macular degeneration (ARMD) is the leading cause of vision loss in aging Westem societies. The objective of the lutein antioxidant supplementation trial (LAST) is to determine whether nutritional supplementation with lutein or lutein together with antioxidants, vitamins, and minerals, improves visual function and symptoms in atrophic ARMD. METHODS The study was a prospective, 12-month, randomized, double-masked, placebo-controlled trial conducted at an urban midwestern Veterans Administration Hospital from August 1999 to May 2001. Ninety patients with atrophic ARMD were referred by ophthalmologists at two Chicago-area veterans medical facilities. Patients in Group 1 received lutein 10 mg (L); in Group 2, a lutein 10 mg/antioxidants/vitamins and minerals broad spectrum supplementation formula (L/A); and in Group 3, a maltodextrin placebo (P) over 12 months. RESULTS In Groups 1 L and 2 L/A, mean eye macular pigment optical density increased approximately 0.09 log units from baseline, Snellen equivalent visual acuity improved 5.4 letters for Group 1 L and 3.5 letters for Group 2 L/A, and contrast sensitivity improved. There was a net subjective improvement in Amsler grid in Group 1 L. VFO-14 questionnaires conceming subjective glare recovery were nearly significant at 4 months for Group 2 L/A. Patients who received the placebo (Group 3) had no significant changes in any of the measured findings. CONCLUSION In this study, visual function is improved with lutein alone or lutein together with other nutrients. Further studies are needed with more patients, of both genders, and for longer periods of time to assess long-term effects of lutein or lutein together with a broad spectrum of antioxidants, vitamins, and minerals in the treatment of atrophic age-related macular degeneration.

[1]  D M Snodderly,et al.  Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. , 1995, The American journal of clinical nutrition.

[2]  E F Cook,et al.  Development of the Activities of Daily Vision Scale: A Measure of Visual Functional Status , 1992, Medical care.

[3]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[4]  J. Castenmiller,et al.  Bioavailability and bioconversion of carotenoids. , 1998, Annual review of nutrition.

[5]  W. Schalch.  Carotenoids in the retina--a review of their possible role in preventing or limiting damage caused by light and oxygen. , 1992, EXS.

[6]  R. Wormald,et al.  Is the incidence of registrable age-related macular degeneration increasing? , 1996, The British journal of ophthalmology.

[7]  D. Snodderly,et al.  Macular pigment density is reduced in obese subjects. , 2002, Investigative ophthalmology & visual science.

[8]  D. Weeks,et al.  Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. , 2001, American journal of ophthalmology.

[9]  W. Willett,et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.

[10]  L. Jampol.  Antioxidants, zinc, and age-related macular degeneration: results and recommendations. , 2001, Archives of ophthalmology.

[11]  R J Glynn,et al.  A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.

[12]  A. Bird,et al.  Age-related macular disease in rural southern Italy. , 1997, Archives of ophthalmology.

[13]  E. Berson.  Nutrition and Retinal Degenerations , 2000, International ophthalmology clinics.

[14]  H. van den Berg.  Carotenoid interactions. , 1999, Nutrition reviews.

[15]  V. Palace,et al.  Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. , 1999, Free radical biology & medicine.

[16]  S. Richer.  ARMD--pilot (case series) environmental intervention data. , 1999, Journal of the American Optometric Association.

[17]  D M Snodderly,et al.  Iris color and macular pigment optical density. , 1996, Experimental eye research.

[18]  T. Maruo,et al.  Changes in causes of visual handicaps in Tokyo. , 1991, Japanese journal of ophthalmology.

[19]  G. Kutty,et al.  Light history and age-related changes in retinal light damage. , 1998, Investigative ophthalmology & visual science.

[20]  R. Russell,et al.  Beta-carotene and other carotenoids as antioxidants. , 1999, Journal of the American College of Nutrition.

[21]  J. Brody,et al.  FACTORS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AN ANALYSIS OF DATA FROM THE FI1R8T NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY , 1988 .

[22]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[23]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[24]  D Carden,et al.  Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. , 2001, Investigative ophthalmology & visual science.

[25]  M. Killingsworth,et al.  Evolution of geographic atrophy of the retinal pigment epithelium , 1988, Eye.

[26]  D. Snodderly,et al.  Cigarette Smoking and Retinal Carotenoids: Implications for Age-related Macular Degeneration , 1996, Vision Research.

[27]  R. Elston,et al.  Oral zinc in macular degeneration. , 1988, Archives of ophthalmology.

[28]  E. Midena,et al.  Macular function impairment in eyes with early age-related macular degeneration. , 1997, Investigative ophthalmology & visual science.

[29]  S. Mayne,et al.  Macular pigment in donor eyes with and without AMD: a case-control study. , 2001, Investigative ophthalmology & visual science.

[30]  J. Brabyn,et al.  Seeing into old age: vision function beyond acuity. , 1999, Optometry and vision science : official publication of the American Academy of Optometry.

[31]  P. Mazurek,et al.  Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. , 1999, Archives of biochemistry and biophysics.

[32]  C. Cross,et al.  Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. , 1996, The American journal of clinical nutrition.

[33]  S. Richer,et al.  Serum Iron, Transferrin Saturation, Ferritin, and Dietary Data in Age-Related Macular Degeneration , 2002, American journal of therapeutics.

[34]  F. Delori,et al.  The macular pigment. II. Spatial distribution in primate retinas. , 1984, Investigative ophthalmology & visual science.

[35]  A C Bird,et al.  [Macular pigment and age-related macular degeneration]. , 2001, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[36]  William G. Cochran,et al.  Experimental Designs, 2nd Edition , 1950 .

[37]  W. Willett,et al.  A prospective study of cigarette smoking and age-related macular degeneration in women. , 1996, Journal of the American Medical Association (JAMA).

[38]  S. Richer,et al.  Nutritional and Environmental Influences on the Eye , 2000 .

[39]  R. Russell,et al.  β-Carotene and Other Carotenoids as Antioxidants , 1999 .

[40]  C. Fjeld,et al.  Food, phytonutrients, and health: rationale for the conference and workshops. , 2009, Nutrition reviews.

[41]  J Brabyn,et al.  The SKILL Card. An acuity test of reduced luminance and contrast. Smith-Kettlewell Institute Low Luminance. , 1997, Investigative ophthalmology & visual science.

[42]  R. Klein,et al.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.

[43]  D. Snodderly,et al.  Dietary modification of human macular pigment density. , 1997, Investigative ophthalmology & visual science.

[44]  R. Knighton,et al.  The photostress recovery test in the clinical assessment of visual function. , 1977, American journal of ophthalmology.

[45]  M Mäntyjärvi,et al.  Normal values for the Pelli‐Robson contrast sensitivity test , 2001, Journal of cataract and refractive surgery.

[46]  F. Khachik,et al.  Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. , 1997, Investigative ophthalmology & visual science.

[47]  V Zemon,et al.  Contrast sensitivity testing: A more complete assessment of vision , 1989, Journal of cataract and refractive surgery.

[48]  D. Thurnham,et al.  Optimal nutrition: vitamin A and the carotenoids , 1999, Proceedings of the Nutrition Society.

[49]  Stuart I. Brown,et al.  The psychosocial impact of macular degeneration. , 1998, Archives of ophthalmology.

[50]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[51]  A protocol for the evaluation and treatment of atrophic age-related macular degeneration. , 1999, Journal of the American Optometric Association.

[52]  D M Snodderly,et al.  A practical method for measuring macular pigment optical density. , 1999, Investigative ophthalmology & visual science.

[53]  J. Dwyer,et al.  Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis: The Los Angeles Atherosclerosis Study , 2001, Circulation.

[54]  Lawrence A. Yannuzzi,et al.  Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .

[55]  Usha Chakravarthy,et al.  Prevalence of age related maculopathy in northern India , 2004 .

[56]  M. J. Luque,et al.  Enhancement of Contrast Sensitivity and Losses of Chromatic Discrimination with Tinted Lenses , 2002, Optometry and vision science : official publication of the American Academy of Optometry.

[57]  O. Sommerburg,et al.  Lutein and zeaxanthin are associated with photoreceptors in the human retina. , 1999, Current eye research.

[58]  S. Lerman.  Photosensitizing drugs and their possible role in enhancing ocular toxicity. Parker Heath memorial lecture. , 1986, Ophthalmology.

[59]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[60]  S. Richer.  Multicenter ophthalmic and nutritional age-related macular degeneration study--part 2: antioxidant intervention and conclusions. , 1996, Journal of the American Optometric Association.